Skip to content

Repeat Late GDM Testing and Cesarean Delivery Rates

Impact of Late Gestational Diabetes Detection and Treatment on Cesarean Delivery Rates After Negative Initial Screening

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07708129
Enrollment
144
Registered
2026-07-16
Start date
2026-08-01
Completion date
2028-05-31
Last updated
2026-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Large for Gestational Age (LGA), Pregnancy

Keywords

Large for gestational age, Ultrasound, Pregnancy

Brief summary

The goal of this randomized trial is determine if re-testing for gestational diabetes in the third trimester after an ultrasound measurement of estimated fetal weight (EFW) or abdominal circumference greater than 90%ile decreases cesarean delivery rate, and to evaluate the optimal method of re-testing. The main question it aims to answer is: Does repeat testing for gestational diabetes and management of hyperglycemia decrease the cesarean delivery rate in fetuses measuring \>90%ile by estimated fetal weight (EFW) or abdominal circumference (AC) on ultrasound in the third trimester. Participants will be randomized into two groups: Group 1 will undergo a repeat glucose tolerance test (GTT) with blinded continuous glucose monitor (CGM) and group 2 will have no intervention. Participants in group 1 will receive nutrition counseling as this would be standard in patients at high risk for gestational diabetes.

Detailed description

This will be a prospective randomized control trial to determine if re-testing for gestational diabetes in the third trimester after an ultrasound measurement of estimated fetal weight (EFW) or abdominal circumference greater than 90%ile decreases cesarean delivery rate, and to evaluate the optimal method of re-testing. Pregnant women will be recruited with gestational age between 30 weeks and 36 weeks gestation with an ultrasound that demonstrates a fetus with either estimated fetal weight (EFW) \>90%, abdominal circumference (AC)\>90% or both. They will be randomized into two groups: Group 1 will undergo a repeat glucose tolerance test (GTT) with blinded continuous glucose monitor (CGM) and group 2 will have no intervention. Participants in group 1 will receive nutrition counseling as this would be standard in patients at high risk for gestational diabetes. The primary outcome is cesarean delivery. Labor course, complications, and delivery/neonatal data will be obtained.

Interventions

DIAGNOSTIC_TESTGlucose tolerance test and continuous glucose monitor

1. Glucose tolerance test 2. Continuous glucose monitoring for two weeks 3. Nutrition counseling

Sponsors

Shauna F. Williams, MD
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Gestational age 30 weeks 0 days and 36 weeks 6 days * Ultrasound with estimated fetal weight or abdominal circumference greater than 90th%ile * Age 18-50 years old.

Exclusion criteria

* Previously diagnosed gestational diabetes or pre-gestational diabetes * Multiple gestation * Previous cesarean delivery * Any condition precluding vaginal delivery (placenta previa/placenta accreta spectrum disorders, vasa previa, prior uterine surgery with contraindication to vaginal delivery) * Suboptimal dating (based on US \>22wk gestation) * Contraindication to glucose tolerance test

Design outcomes

Primary

MeasureTime frame
Rate of cesarean deliveryFrom enrollment until delivery

Contacts

CONTACTRebecca Bradley, DO
rlb310@njms.rutgers.edu973-862-5262
CONTACTShauna Williams, MD
williash@njms.rutgers.edu973-972-5262
PRINCIPAL_INVESTIGATORShauna Williams, MD

Rutgers Health New Jersey Medical School

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 17, 2026